Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response

Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response

Background CD47 is an integral membrane protein that alters adaptive immunosurveillance when bound to the matricellular glycoprotein thrombospondin-1 (TSP1). We examined the impact of the CD47/TSP1 signaling axis on melanoma patient response to anti-PD-1 therapy due to alterations in T cell activati...

Full description

Bibliographic Details
Main Authors:	Wei Zhang, Masaki Terabe, Lance D Miller, Mitra Kooshki, Pierre L Triozzi, Elizabeth R Stirling, Adam S Wilson, Liliya M Yamaleyeva, Martha A Alexander-Miller, David R Soto-Pantoja
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-11-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/11/e004712.full

Similar Items

Functions of Thrombospondin-1 in the Tumor Microenvironment
by: Sukhbir Kaur, et al.
Published: (2021-04-01)

616 CD47 blockade modulates immunosuppressive checkpoint molecules and cellular metabolism to sensitize triple-negative breast cancer tumors to immune checkpoint blockade therapy
by: Pierre Triozzi, et al.
Published: (2021-11-01)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
by: Sajin Rajbhandary, et al.
Published: (2023-05-01)

Metabolic Implications of Immune Checkpoint Proteins in Cancer
by: Elizabeth R. Stirling, et al.
Published: (2022-01-01)

Durable antitumor responses to CD47 blockade require adaptive immune stimulation
by: Sockolosky, Jonathan T., et al.
Published: (2016)

Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine
by: Atharva Kale, et al.
Published: (2021-04-01)

“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
by: Katherine L. Cook, et al.
Published: (2017-08-01)

Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
by: Qian Xu, et al.
Published: (2023-09-01)

Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy
by: Xueqing Sui, et al.
Published: (2020-09-01)

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity
by: Bin Zhang, et al.
Published: (2022-06-01)

Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications
by: Binghao Zhao, et al.
Published: (2023-03-01)

Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment
by: Jie Guo, et al.
Published: (2023-05-01)

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
by: Alireza Labani-Motlagh, et al.
Published: (2020-05-01)

Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
by: Cristiana Tanase, et al.
Published: (2022-01-01)

Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
by: Pedro Rodríguez-Jiménez, et al.
Published: (2019-06-01)

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
by: Lan Yu, et al.
Published: (2021-12-01)

HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity
by: Andrew Nguyen, et al.
Published: (2022-10-01)

CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
by: Rosanna Mezzapelle, et al.
Published: (2021-06-01)

PARASITIZED ERYTHROCYTE BINDING TO THROMBOSPONDIN IN FALCIPARUM-MALARIA
by: Sherwood, J, et al.
Published: (1986)

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity
by: Martina Chirra, et al.
Published: (2022-07-01)

Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
by: Ping Yu, et al.
Published: (2023-10-01)

Editorial: New insights into antitumor mechanisms based on breast cancer immune microenvironment
by: Yan Yao, et al.
Published: (2023-07-01)

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
by: Yuheng Yan, et al.
Published: (2022-08-01)

Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity.
by: Sara McMaken, et al.
Published: (2011-05-01)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
by: Ying Zhu, et al.
Published: (2020-04-01)

The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer.
by: Kenji Kuroda, et al.
Published: (2019-01-01)

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.
by: Steven E Kauder, et al.
Published: (2018-01-01)

Impact of maximal exercise on immune cell mobilization and bioenergetics
by: James E. Stampley, et al.
Published: (2023-06-01)

The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes
by: Calina Betlazar, et al.
Published: (2020-02-01)

Antitumor Immunity and Dietary Compounds
by: Annalise R. Smith, et al.
Published: (2013-12-01)

Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
by: Sang Jun Han, et al.
Published: (2022-10-01)

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
by: Xiao Yang, et al.
Published: (2022-01-01)

Thrombospondin binding by parasitized erythrocyte isolates in falciparum malaria.
by: Sherwood, J, et al.
Published: (1987)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
by: Peng Zhang, et al.
Published: (2023-03-01)

oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity
by: Wen Zhang, et al.
Published: (2020-03-01)

Induction of antitumor immunity through xenoplacental immunization
by: Agadjanyan Michael G, et al.
Published: (2006-05-01)

Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment
by: Kexiang Sun, et al.
Published: (2022-09-01)

Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low‐dose metformin
by: Yusheng Lin, et al.
Published: (2021-08-01)

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
by: Elizabeth Repasky, et al.
Published: (2021-01-01)

Diabetes Impairs Angiogenesis and Induces Endothelial Cell Senescence by Up-Regulating Thrombospondin-CD47-Dependent Signaling
by: Milad S. Bitar
Published: (2019-02-01)